MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock
$18,303,312
Proceeds from warrants
exercised
$3,620,657
Proceeds from bridge note
$3,000,000
Net cash flows from
financing activities
$19,927,282
Canceled cashflow
$4,996,687
Net change in cash
and cash...
-$9,037,229
Canceled cashflow
$19,927,282
Stock compensation
expense
$6,424,730
Amortization of debt discount
$481,424
Other current assets
-$457,523
Loss on share
issuance to kineta...
$185,019
Other noncurrent
assets
-$154,998
Depreciation and
amortization
$71,265
Payment of offering
costs associated with...
$1,555,307
Payment of bridge note
$1,500,000
Payment of net
liabilities assumed in...
$550,000
Payment of merger
transaction costs
$500,000
Repayment of assumed
kineta indeptedness
$434,000
Payments made on kineta
severance promissory...
$394,709
Payments on equipment
lease
$54,315
Series a preferred
dividend
$8,356
Net cash flows from
operating activities
-$27,629,150
Canceled cashflow
$7,774,959
Net cash flows from
investing activities
-$1,335,361
Net loss
-$30,051,977
Accounts payable and
accrued expenses
-$3,761,184
Change in fair value of
holdback shares
-$1,590,948
Cash paid for kineta
acquisition, net of assumed...
$1,259,278
Purchase of property and
equipment
$76,083
Back
Back
Cash Flow
source: myfinsight.com
TuHURA Biosciences, Inc. NV (HURA)
TuHURA Biosciences, Inc. NV (HURA)